146 related articles for article (PubMed ID: 10660737)
41. [Raltitrexed in colorectal cancer].
Comandone A; Oliva C; Dal Canton O; Boglione A; Bergnolo P
Tumori; 2001; 87(1 Suppl 1):S53-4. PubMed ID: 11300026
[No Abstract] [Full Text] [Related]
42. Preoperative chemoradiation with raltitrexed ('Tomudex') for T2/N+ and T3/N+ rectal cancers: a phase I study.
Valentini V; Doglietto GB; Morganti AG; Turriziani A; Smaniotto D; De Santis M; Ratto C; Sofo L; Cellini N
Eur J Cancer; 2001 Nov; 37(16):2050-5. PubMed ID: 11597383
[TBL] [Abstract][Full Text] [Related]
43. Raltitrexed (Tomudex) concomitant with radiotherapy as adjuvant treatment for patients with rectal cancer: preliminary results of phase I studies.
James R; Price P; Valentini V
Eur J Cancer; 1999 Mar; 35 Suppl 1():S19-22. PubMed ID: 10645210
[TBL] [Abstract][Full Text] [Related]
44. Drug resistance in colon cancer.
Gorlick R; Bertino JR
Semin Oncol; 1999 Dec; 26(6):606-11. PubMed ID: 10606253
[TBL] [Abstract][Full Text] [Related]
45. Efficacy, tolerability and management of raltitrexed (Tomudex) monotherapy in patients with advanced colorectal cancer. a review of phase II/III trials.
Cunningham D; Zalcberg J; Maroun J; James R; Clarke S; Maughan TS; Vincent M; Schulz J; González Barón M; Facchini T
Eur J Cancer; 2002 Mar; 38(4):478-86. PubMed ID: 11872339
[TBL] [Abstract][Full Text] [Related]
46. Phase II study of raltitrexed ('Tomudex') for patients with advanced soft tissue sarcomas refractory to doxorubicin-containing regimens.
Blay JY; Judson I; Rodenhuis S; Hermans C; Smith M; van Glabbeke M; Verweij J
Anticancer Drugs; 1999 Nov; 10(10):873-7. PubMed ID: 10630354
[TBL] [Abstract][Full Text] [Related]
47. Real-world Safety and Efficacy of Raltitrexed in Patients With Metastatic Colorectal Cancer.
Batra A; Rigo R; Hannouf MB; Cheung WY
Clin Colorectal Cancer; 2021 Jun; 20(2):e75-e81. PubMed ID: 33268287
[TBL] [Abstract][Full Text] [Related]
48. Phase II trial of raltitrexed ('Tomudex') in advanced small-cell lung cancer.
Woll PJ; Basser R; Le Chevalier T; Drings P; Perez Manga G; Adenis A; Seymour L; Smith F; Thatcher N
Br J Cancer; 1997; 76(2):264-5. PubMed ID: 9231930
[TBL] [Abstract][Full Text] [Related]
49. 'Tomudex' (raltitrexed) development: preclinical, phase I and II studies.
Judson IR
Anticancer Drugs; 1997 Aug; 8 Suppl 2():S5-9. PubMed ID: 9376637
[TBL] [Abstract][Full Text] [Related]
50. Overview of the tolerability of 'Tomudex' (raltitrexed): collective clinical experience in advanced colorectal cancer.
Zalcberg J
Anticancer Drugs; 1997 Aug; 8 Suppl 2():S17-22. PubMed ID: 9376633
[TBL] [Abstract][Full Text] [Related]
51. [A phase II study of ranomustine (MCNU) tablets in patients with gastrointestinal cancer--by cooperative study group].
Taguchi T
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2420-6. PubMed ID: 6497400
[TBL] [Abstract][Full Text] [Related]
52. [Irinotecan and tomudex in the treatment of patients with advanced cancer of the large intestine].
Reutova EV
Vopr Onkol; 2001; 47(6):731-5. PubMed ID: 11826499
[TBL] [Abstract][Full Text] [Related]
53. Thymidylate synthase mRNA levels in plasma and tumor as potential predictive biomarkers for raltitrexed sensitivity in gastric cancer.
Shen J; Wang H; Wei J; Yu L; Xie L; Qian X; Zou Z; Liu B; Guan W
Int J Cancer; 2012 Sep; 131(6):E938-45. PubMed ID: 22422354
[TBL] [Abstract][Full Text] [Related]
54. Clinical trials referral resource. Clinical trials with tomudex.
Sorensen JM; Cheson BD; Phillips PH
Oncology (Williston Park); 1996 Jul; 10(7):1041-2. PubMed ID: 8837120
[No Abstract] [Full Text] [Related]
55. Raltitrexed treatment promotes systemic inflammatory reaction in patients with colorectal carcinoma.
Osterlund P; Orpana A; Elomaa I; Repo H; Joensuu H
Br J Cancer; 2002 Sep; 87(6):591-9. PubMed ID: 12237767
[TBL] [Abstract][Full Text] [Related]
56. Phase II evaluation of DON (6-diazo-5-oxo-L-norleucine) in patients with advanced colorectal carcinoma.
Lynch G; Kemeny N; Casper E
Am J Clin Oncol; 1982 Oct; 5(5):541-3. PubMed ID: 7180833
[TBL] [Abstract][Full Text] [Related]
57. Vindesine in the treatment of advanced colorectal cancer: a phase II study.
Diaz-Rubio E; Martin-Jimenez M
Cancer Treat Rep; 1984 Mar; 68(3):555-6. PubMed ID: 6704985
[No Abstract] [Full Text] [Related]
58. Phase II evaluation of 4'-epi-doxorubicin in patients with advanced colorectal carcinoma.
Michaelson R; Kemeny N; Young C
Cancer Treat Rep; 1982 Sep; 66(9):1757-8. PubMed ID: 6956441
[TBL] [Abstract][Full Text] [Related]
59. 'Tomudex' (ZD1694): a novel thymidylate synthase inhibitor with clinical antitumour activity in a range of solid tumours. 'Tomudex' International Study Group.
Cunningham D; Zalcberg J; Smith I; Gore M; Pazdur R; Burris H; Meropol NJ; Kennealey G; Seymour L
Ann Oncol; 1996 Feb; 7(2):179-82. PubMed ID: 8777175
[TBL] [Abstract][Full Text] [Related]
60. Raltitrexed, a new drug for advanced colorectal cancer.
Mead GM
Lancet; 1996 Jun; 347(9015):1568-9. PubMed ID: 8667859
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]